Remedium Technologies, Inc.

Basic Information

387 Technology Dr.
College Park, MD, 20742-3371

Company Profile

n/a

Additional Details

Field Value
DUNS: 808674217
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 1


  1. SBIR Phase II: Sprayable Reversible Hemostat for Treatment of Non-Compressible Hemorrhage

    Amount: $500,000.00

    This Small Business Innovation Research (SBIR) Phase II project aims to develop a sprayable foam hemostat for treatment of non-compressible hemorrhage, which is the leading cause of death (~90%) for b ...

    SBIR Phase II 2013 National Science Foundation
  2. SBIR Phase I: Sprayable Reversible Hemostat for Treatment of Non-Compressible Hemorrhage

    Amount: $150,000.00

    This Small Business Innovation Research (SBIR) Phase I project aims to develop a sprayable "reversible" foam hemostat for treatment of non-compressible hemorrhage, which is the leading cause ...

    SBIR Phase I 2012 National Science Foundation

Agency Micro-sites

US Flag An Official Website of the United States Government